One Year of Alendronate after One Year of Parathyroid Hormone (1–84) for Osteoporosis

Abstract

After one year of parathyroid hormone (1-84), densitometric gains appear to be maintained or increased with alendronate but lost if parathyroid hormone is not followed by an antiresorptive agent. These results have clinical implications for therapeutic choices after the discontinuation of parathyroid hormone.